A papilomatose respiratória recorrente é uma doença respiratória rara caracterizada pelo desenvolvimento de papilomas exofíticos, acometendo a mucosa do trato aerodigestivo superior (com forte predileção pela laringe), causada por infecção pelo vírus do papiloma humano. Os sintomas de apresentação podem incluir rouquidão, tosse crônica, dispneia, infecções respiratórias superiores recorrentes, pneumonia, disfagia, estridor e/ou retardo de crescimento.
Introdução
O que você precisa saber de cara
A papilomatose respiratória recorrente é uma condição respiratória rara provocada pela infecção pelo vírus do papiloma humano, caracterizada por lesões conhecidas como papilomas na mucosa da laringe e das vias aéreas. A família costuma perceber sinais como voz rouca constante, ruídos durante a respiração conhecidos como estridor, tosse frequente e episódios de engasgos ou dificuldade para respirar. No cenário mundial, existe medicamento aprovado pelo FDA norte-americano, como o PAPZIMEOS (zopapogene imadenovec), além de pesquisas avaliando novas terapias adjuvantes. No Brasil, a doença ainda não consta na lista oficial de Protocolos Clínicos e Diretrizes Terapêuticas do Ministério da Saúde, sendo o suporte clínico viabilizado pela rede pública assistencial de saúde.
A papilomatose respiratória recorrente é uma doença respiratória rara caracterizada pelo desenvolvimento de papilomas exofíticos, acometendo a mucosa do trato aerodigestivo superior (com forte predileção pela laringe), causada por infecção pelo vírus do papiloma humano. Os sintomas de apresentação podem incluir rouquidão, tosse crônica, dispneia, infecções respiratórias superiores recorrentes, pneumonia, disfagia, estridor e/ou retardo de crescimento.
Tem tratamento?
Escala de raridade
<1/50kMuito rara
1/20kRara
1/10kPouco freq.
1/5kIncomum
1/2k
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Partes do corpo afetadas
+ 12 sintomas em outras categorias
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 23 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Nenhum gene associado encontrado
Os dados genéticos desta condição ainda estão sendo catalogados.
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Papilomatose respiratória recorrente
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Ensaios em destaque
Com ensaio aberto em 4 países. O ponto verde marca onde há vaga agora.
🟢 Recrutando agora
5 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.
Outros ensaios clínicos
31 ensaios clínicos encontrados, 9 ativos.
Publicações mais relevantes
Intralesional bevacizumab as an adjuvant approach to recurrent respiratory papillomatosis: A prospective study on different treatment protocols.
Adjuvant intralesional administration of bevacizumab has shown promising effects in the management of recurrent respiratory papillomatosis (RRP). However, the optimal therapeutic parameters remain undefined. This prospective study aimed to compare the efficacy of two distinct intralesional bevacizumab administration protocols following surgical resection of RRP. Between 15/09/2023 and 31/12/2024, adult patients with RRP were enrolled in a prospective research study. Participants were allocated to one of two bevacizumab administration protocols, delivered intralesional during direct microlaryngoscopy and CO₂ laser excision. Disease severity was assessed using the Derkay, Dikkers and Numerical scoring systems, as well as the Voice Handicap Index (VHI), at baseline and at 8-week intervals. Both treatment regimens were associated with reduction in disease burden and improved voice outcomes. No statistically significant differences in disease control were observed between the two administration protocols. This study indicates that both dosing regimens of bevacizumab were effective as an adjunctive therapy of recurrent respiratory papillomatosis. The higher intralesional doses of bevacizumab are relatively safe and well tolerated in adult patients with laryngeal RRP. Further studies with extended follow-up are warranted to define long-term efficacy and optimal dosing strategies.
Surgical and Voice Outcomes of Office-Based Recurrent Respiratory Papillomatosis Surgery: A Systematic Review.
To investigate the surgical and voice outcomes associated with office-based laryngeal surgery for the treatment of recurrent respiratory papillomatosis (RRP). PubMed, Google Scholar, and Cochrane databases. Two independent investigators search databases for studies reporting surgical or voice quality outcomes of patients treated with office-based surgery for RRP according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Primary outcomes consisted of surgical (safety, patient tolerance, recurrence, complications, number of interventions) and voice quality (subjective, aerodynamic, and acoustic measurements) outcomes. The bias analysis was conducted through the Methodological Index for Non-Randomized Studies (MINORS). Fifteen studies (13 retrospective, 2 prospective) met inclusion criteria, accounting for 357 patients with RRP mainly treated with PDL, KTP, and Blue Laser office-based surgery. Surgical outcomes reported 50% to 95.8% lesion regression rates. The patient tolerance was good, with smokers reporting the low level of tolerance. The cumulative complication rate was low (1.62%). Voice quality assessments demonstrated significant improvements in subjective measures (VHI-10, GRBAS), while there was no study reporting multidimensional voice quality assessments including subjective, perceptual, aerodynamic, and acoustics measurements. Methodological quality of included studies was low-to-moderate (MINORS scores: 5-9), with inconsistent reporting of confounding factors. Office-based laser surgery is a safe and effective treatment for vocal fold RRP, with an effective reduction of disease burden, satisfactory regression, and a moderate rate of subsequent need for OR management. Future studies are needed to investigate the long-term multidimensional voice quality outcomes related to office-based procedures and to compare them with operating room procedures.
Risk factors for perioperative respiratory adverse events and unplanned intensive care admission in children with juvenile-onset recurrent respiratory papillomatosis undergoing carbon dioxide laser resection.
To identify risk factors for perioperative respiratory adverse events (PRAEs) and unplanned intensive care admission (UIA) in children with juvenile-onset recurrent respiratory papillomatosis (JORRP) undergoing carbon dioxide (CO₂) laser resection. This retrospective nested case-control study included 148 JORRP patients who underwent CO₂ laser resection between 2014 and 2023 at Sun Yat-sen Memorial Hospital. Univariate and multivariate logistic regression analyses were used to identify independent risk factors. Predictive nomograms were constructed based on the multivariate model. PRAEs were defined as laryngeal edema, bronchospasm, desaturation, emergency reintubation, or tracheostomy occurring within 24 hours post-surgery. Forty patients (27.0%) required UIA, of whom 36 (24.3% of the total cohort) experienced PRAEs that led to ICU admission. Median age at surgery was 3.8 years. Female sex (OR=4.00, 95% CI 1.07 to 15.87), number of previous surgeries (OR=16.05, 95% CI 3.86 to 66.78), younger age (per year increase, OR=0.70, 95% CI 0.53 to 0.94), longer duration of surgery (OR=1.01, 95% CI 1.01 to 1.02), and tracheal involvement (OR=5.58, 95% CI 1.27 to 24.55) were identified as significant independent risk factors for PRAEs. Similar patterns were observed for UIA. Nomogram analysis demonstrated that young female patients with multiple previous surgeries, prolonged surgical times, and tracheal tumors had the highest risk of respiratory complications. Patients who are female, younger, have tracheal involvement, multiple previous surgeries, and prolonged operative duration are at significantly higher risk for PRAEs and UIA following CO₂ laser resection for JORRP. These findings provide valuable insights for optimizing perioperative management and improving patient safety in this vulnerable population.
Therapeutic vaccination for active induction of T cell immunity against cancer, ready for a rich harvest after 40 years.
Therapeutic vaccines include DNA, mRNA, protein-loaded antigen-presenting cell, synthetic long peptide (SLP) and recombinant virus platforms. Only two therapeutic vaccines for neoplastic disease were approved by the Food and Drug Administration in the past 40 years: sipuleucel-T, approved in 2010 for hormone-resistant metastatic prostate cancer and targeting prostate acid phosphatase; and zopapogene imadenovec, approved in 2025 for recurrent respiratory papillomatosis, a rare, non-malignant but often invalidating disease caused by human papillomavirus (HPV) type 6 or type 11. In the last decade, DNA, mRNA and SLP vaccines directed against mutation-derived neoantigens have shown strong immunogenicity for T cells and clinical activity with or without additional immune checkpoint inhibition. Vaccine monotherapy is effective in premalignant disorders caused by high-risk HPV16 and virus-negative colonic polyps. Treatment of bulky or recurrent/metastatic (R/M) disease requires combination with surgery and/or chemotherapy or combination with an immune checkpoint inhibitor such as PD-1 blocker. In a recent study, adjuvant treatment with neoantigen-specific mRNA vaccine plus PD-1 blocker led to less melanoma recurrence than PD-1 blocker alone. In another randomized study, patients with R/M HPV16+ head and neck cancer only benefited from the combination of HPV16-specific SLP vaccine and a PD-1 blocker if they had high pretreatment PD-L1 biomarker expression in cancer tissue. Increasingly, biomarker-guided therapy is recommended.
The Patient Perspective of Living With Recurrent Respiratory Papillomatosis.
Recurrent Respiratory Papillomatosis (RRP) is caused by human papillomavirus (HPV) types 6 and 11, and afflicts children (Jo-RRP, Juvenile-onset RRP) and adults (Ao-RRP, adult-onset RRP). The study objective was to describe the disease burden of RRP from three patient-relevant perspectives: economic, clinical, and humanistic. A retrospective descriptive analysis of responses to questionnaires captured within a linked Coordination of Rare Diseases (CoRDS) and the Recurrent Respiratory Papillomatosis Foundation (RRPF) (CoRDS/RRPF) patient registries from May 1, 2019, to July 31, 2023 was performed. Categorical variables were summarized using counts and proportions and continuous variables were summarized using means (standard deviations) and medians (interquartile ranges). Responses from 122 participants, 55% (67/122) Jo-RRP and 45% (55/122) Ao-RRP, were included. Forty-one percent (41/99) traveled more than 100 miles round trip to receive specialty care, and 61% (52/85) spent > 5% of their family income to pay for care. RRP resulted in increased absences from school [94% (17/18) for participants aged < 22] and work [85.5% (65/76) for participants aged > 22]. Moreover, 64.9% (48/74) of respondents perceived that RRP negatively impacted their careers. Feelings of isolation (70%) and depression (45.1%) were common, but less than 25% of respondents reported seeking mental health assistance. RRP leads to clinical, financial, and psychosocial burdens. Increased public awareness regarding HPV infection of the airway is needed, as this disease is preventable through HPV vaccination.
Publicações recentes
Development of a novel prognostic assessment tool for recurrent respiratory papillomatosis.
Systemic Bevacizumab Therapy in Recurrent Respiratory Papillomatosis: First Preliminary Study From Azerbaijan.
Rare case of recurrent respiratory papillomatosis with malignant transformation.
In-Office Management of Eustachian Tube Dysfunction Secondary to Recurrent Respiratory Papillomatosis of the Nasopharynx: A Novel Approach to a Rare Condition.
Surgical and Voice Outcomes of Office-Based Recurrent Respiratory Papillomatosis Surgery: A Systematic Review.
📚 EuropePMC746 artigos no totalmostrando 199
Surgical and Voice Outcomes of Office-Based Recurrent Respiratory Papillomatosis Surgery: A Systematic Review.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck SurgeryRisk factors for perioperative respiratory adverse events and unplanned intensive care admission in children with juvenile-onset recurrent respiratory papillomatosis undergoing carbon dioxide laser resection.
World journal of pediatric surgeryTherapeutic vaccination for active induction of T cell immunity against cancer, ready for a rich harvest after 40 years.
Journal for immunotherapy of cancerThe Patient Perspective of Living With Recurrent Respiratory Papillomatosis.
The LaryngoscopeSuccessful Use of Argon Plasma Coagulation in the Treatment of Multiple Recurrent Lower Tract Papillomatosis: A Case Report.
Respirology case reportsIntralesional bevacizumab as an adjuvant approach to recurrent respiratory papillomatosis: A prospective study on different treatment protocols.
PloS oneRecurrent respiratory papillomatosis: Recent advances in HPV-6/HPV-11-targeted immunotherapy.
Asian Pacific journal of allergy and immunologyCan we use peak expiratory flow rate monitoring in recurrent respiratory papillomatosis?
International journal of pediatric otorhinolaryngologyRecurrent respiratory papillomatosis: is patient well-being related to anatomical manifestation?
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck SurgeryJuvenile-Onset Recurrent Respiratory Papillomatosis and Human Papillomavirus Vaccine Uptake: A 19-Year Retrospective Cohort Study.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck SurgeryNasal Sublesional Bevacizumab Injections as Adjuvant Treatment for Diffuse Sinonasal Exophytic Papillomas.
Journal of clinical medicineAustralian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2024.
Communicable diseases intelligence (2018)Immunohistochemical Expression of p16 and Its Association with Recurrence in Adult-Onset Recurrent Respiratory Papillomatosis: A Preliminary Study.
Journal of voice : official journal of the Voice FoundationRecurrent Respiratory Papillomatosis Foundation Position Statement on the Management of Adults With RRP.
The LaryngoscopeContemporary management of recurrent respiratory papillomatosis: a survey of Australian otolaryngologists.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck SurgeryRecurrent respiratory papillomatosis treated with combined erlotinib and celecoxib: A retrospective study.
Medicina clinicaAggressive Juvenile-Onset Respiratory Papillomatosis in a High HIV Prevalence Setting: Clinical Predictors of Severity in South Africa.
Open forum infectious diseasesCodon usage bias of low-risk human papillomavirus types 6 and 11.
Antonie van LeeuwenhoekValidation of Narrow Band Imaging in Recurrent Respiratory Papillomatosis Using Severity Scales.
The LaryngoscopeThe use of intralesional & systemic bevacizumab in severe recurrent respiratory papillomatosis: A case report.
International journal of pediatric otorhinolaryngologyNationwide Survey on Recurrent Respiratory Papillomatosis in Japan: Analysis of Long-Term Patients.
The Laryngoscope[Application of transnasal humidified rapid-insufflation ventilatory exchange in anesthesia for juvenile-onset recurrent respiratory papillomatosis surgery].
Zhonghua yi xue za zhiFrom surgery to immunotherapy: Papzimeos as the first FDA-approved therapy for recurrent respiratory papillomatosis (RRP).
Annals of medicine and surgery (2012)Public health impact and cost-effectiveness of implementing gender-neutral immunization with the nonavalent human papillomavirus vaccine in South Korea.
Human vaccines & immunotherapeuticsIn Reference to A Clinical Consensus Statement on Pulmonary Recurrent Respiratory Papillomatosis.
The LaryngoscopeZopapogene Imadenovec: First Approval.
Molecular diagnosis & therapyFactors Influencing Laryngeal Web After Surgery Combined With Photodynamic Therapy in RRP.
The LaryngoscopeIn Response to A Clinical Consensus Statement on Pulmonary Recurrent Respiratory Papillomatosis.
The LaryngoscopeIs there a Role for Narrow Band Imaging (NBI) in the Identification of Recurrent Respiratory Papillomatosis (RRP)?
Journal of voice : official journal of the Voice FoundationSuccessful immunotherapy using adenovector gene therapy for the treatment of recurrent respiratory papillomatosis.
Molecular therapy : the journal of the American Society of Gene TherapyThe Derkay Scale as a Predictor of Voice Dysfunction in Recurrent Respiratory Papillomatosis: Correlations Between Acoustic and Patient-Reported Outcomes.
Journal of clinical medicineRelationship between age at diagnosis and recurrence characteristics in adult-onset recurrent respiratory papillomatosis: a nationwide multicenter study from China.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious DiseasesHealth impact and cost-effectiveness analysis of gender-neutral versus female-only 9-valent human papillomavirus vaccination in Taiwan.
PloS onePulmonary Dissemination in Adult-Onset Recurrent Respiratory Papillomatosis: A Rare and Severe Manifestation.
Respirology case reportsProlonged Treatment Gaps and Recurrence Patterns in Recurrent Respiratory Papillomatosis.
The LaryngoscopeRelación entre genotipo y carga viral de virus del papiloma humano y la gravedad de presentación de la papilomatosis respiratoria recurrente en niños.
Boletin medico del Hospital Infantil de MexicoStandardisation of an AI-based vocal fold assessment tool on a recurrent respiratory papillomatosis model.
Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-faccialeRecurrent lesion distribution after photodynamic therapy for recurrent respiratory papillomatosis.
Photodiagnosis and photodynamic therapyChinese guideline for the diagnosis and treatment of juvenile-onset recurrent respiratory papillomatosis (2024).
World journal of otorhinolaryngology - head and neck surgeryAn exploratory study of human papillomavirus detection in oral rinses from patients with recurrent respiratory papillomatosis.
Fukushima journal of medical scienceHPV vaccination improves immune response in children with respiratory papillomatosis.
Scientific reports[Expert consensus on the early prevention of human papillomavirus related non-cervical diseases (2025 edition)].
Zhonghua yi xue za zhiDNA Immunotherapy (INO-3107) Results in Long-Term Surgery Reduction in RRP.
The LaryngoscopeA Clinical Consensus Statement on Pulmonary Recurrent Respiratory Papillomatosis.
The LaryngoscopeAn Observational Study of the Prevalence of Oral Human Papilloma Virus Infection in Laryngologists.
The Laryngoscope[Expert consensus on comprehensive prevention and control strategies for human papillomavirus associated diseases].
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]The role of tumor-associated neutrophils in the pathogenesis of recurrent respiratory papillomatosis.
Journal of leukocyte biologyLocal T-Cell Dysregulation and Immune Checkpoint Expression in Human Papillomavirus-Mediated Recurrent Respiratory Papillomatosis.
CellsShould All Patients With Recurrent Respiratory Papillomatosis Be Vaccinated for HPV?
The LaryngoscopeRecurrent respiratory papillomatosis causing critical airway obstruction in the third trimester of pregnancy.
BMJ case reportsHuman Papillomavirus Exposure Risk and Vaccination Awareness Among Laryngeal Surgeons: A Worldwide Survey Study.
The LaryngoscopeCharacteristics of juvenile-onset recurrent respiratory papillomatosis in China, 2011-2021: A hospital-based nationwide study.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious DiseasesA scoping review of human papillomavirus related data system in China.
BMC infectious diseasesImpact of COVID-19 on management and outcomes of NHS patients with recurrent respiratory papillomatosis: evidence from a UK registry.
Annals of the Royal College of Surgeons of EnglandRecurrent respiratory papillomatosis in children: coblation versus microdebrider.
The Journal of laryngology and otologyPathogenesis of recurrent respiratory papillomatosis and potential novel treatment strategies.
Auris, nasus, larynxProjected health and economic effects of nonavalent versus bivalent human papillomavirus vaccination in preadolescence in the Netherlands.
BMC medicineHPV6-Induced Gene Expression Signature in Recurrent Respiratory Papillomatosis.
The LaryngoscopePhysician Attitudes Towards Corticosteroid Usage in Patients With Recurrent Respiratory Papillomatosis: A National Survey.
Journal of voice : official journal of the Voice FoundationImproved Tubeless Airway Management in JORRP Surgery: Comparative Analysis of Pre- and Post-THRIVE Implementation.
Therapeutics and clinical risk managementCurrent treatment options for recurrent respiratory papillomatosis: A narrative review.
Auris, nasus, larynxDisease Control and Voice Outcomes Following Treatment With PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis.
Journal of voice : official journal of the Voice FoundationDysplasia and Carcinoma in Recurrent Respiratory Papillomatosis Patients Older Than 45 Years.
The LaryngoscopeA Case of Malignant Transformation of Recurrent Respiratory Papillomatosis That Was Effectively Treated with Pembrolizumab.
Case reports in oncologyA young female with multiple cavitary lung lesions.
Respiratory medicine case reportsHPV Infection in Children and Adolescents-A Comprehensive Review.
Journal of clinical medicineLaryngeal Papillomatosis.
CancersTherapeutic Impact of Gardasil® in Recurrent Respiratory Papillomatosis: A Retrospective Study on RRP Patients.
VirusesAustralian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2023.
Communicable diseases intelligence (2018)[Preoperative anesthesia risk assessment factors in young children with severe recurrent respiratory papillomatosis].
Zhonghua yi xue za zhiUpdate on Gardasil Vaccination in Recurrent Respiratory Papillomatosis Patients Aged 45 or Older.
The LaryngoscopeA cost-effectiveness analysis of adult human papillomavirus vaccination strategies in Italy.
Human vaccines & immunotherapeuticsMajor Human Leukocyte Antigen Expression in Respiratory Papillomatosis Clinical Specimens.
The LaryngoscopeNonlinear relationship between operational frequency and age in respiratory papillomatosis patients.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck SurgeryRecurrent respiratory papillomatosis: role of bevacizumab and HPV vaccination. A literature review with case presentations.
Radiology and oncologyImpact of HPV Types and Dendritic Cells on Recurrent Respiratory Papillomatosis' Aggressiveness.
Diseases (Basel, Switzerland)DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1/2 study assessing efficacy, safety, and immunogenicity of INO-3107.
Nature communicationsRecurrent respiratory papillomatosis in adults with lower respiratory tract involvement: a retrospective study of the OrphaLung and GETIF networks.
The European respiratory journalA high-impact study and landmark achievement in the treatment of recurrent respiratory papillomatosis.
The Lancet. Respiratory medicinePRGN-2012 gene therapy in adults with recurrent respiratory papillomatosis: a pivotal phase 1/2 clinical trial.
The Lancet. Respiratory medicine[Clinical observation on rapid relief of dyspnea in juvenile-onset recurrent respiratory papillomatosis treated with bevacizumab].
Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgeryTinnitus and dementia risk, adjuvant treatments for recurrent respiratory papillomatosis and is frontal sinus pain a useful marker of chronic frontal sinusitis?
The Journal of laryngology and otologyHPV Vaccination in a Case of JORRP, a Variety of RRP in Bangladesh Medical College Hospital: A Case Report.
Mymensingh medical journal : MMJThe Recurrence of Tracheobronchial Papillomatosis Following Prostate Cancer Diagnosis.
CureusEmergency Debulking of Recurrent Respiratory Papillomatosis: An Anesthesia Challenge.
Cureus"A systematic literature review of the epidemiology, clinical, economic and humanistic burden in recurrent respiratory papillomatosis".
Respiratory researchTrends in the incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis following implementation of national HPV vaccination initiatives: a systematic review.
Acta oto-laryngologicaNationwide Survey on Incidence and Management of Recurrent Respiratory Papillomatosis in Japan.
The LaryngoscopePrevalence and risk factors for dysplasia and malignancy in a large cohort of patients with recurrent respiratory papillomatosis.
The Journal of laryngology and otologyLong-Term Infection With a Particular Human Papillomavirus (HPV) Genotype, HPV Subtype, or HPV Genomic Variant Does not Significantly Influence the Clinical Course of Recurrent Respiratory Papillomatosis.
Journal of medical virologyRecurrent respiratory papillomatosis: Immunological mechanisms involved in recurrence.
International reviews of immunologyGenomic diversity of HPV6 and HPV11 in recurrent respiratory papillomatosis: Association with malignant transformation in the lungs and clinical outcomes.
Tumour virus research[Update on HPV-associated head and neck cancers-highlights of the 2024 ASCO Annual Meeting].
HNOCurrent Practice, Safety and Efficacy of Interventions for Recurrent Respiratory Papillomatosis: Evidence From a UK Registry.
Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial SurgeryEffective control of a severely progressive recurrent respiratory papillomatosis with repetitive cryotherapy.
The Korean journal of internal medicineRecurrent Respiratory Papillomatosis in the Post-Human Papillomavirus Vaccination Era.
JAMA pediatricsAdjuvant treatments for recurrent respiratory papillomatosis: a descriptive review and proposed management guideline in adults.
The Journal of laryngology and otologyEvaluating the efficacy and safety of intralesional bevacizumab in the treatment of recurrent respiratory papillomatosis: A systematic review.
International journal of pediatric otorhinolaryngologyAdvances in Recurrent Respiratory Papillomatosis Treatment: Adjuvant Intralesional Bevacizumab's Impact, Potential and Insights from a Case Series Study.
Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of IndiaSuccessful Bevacizumab Therapy in a 25-Year-Old Patient with Recurrent Respiratory Papillomatosis.
European journal of case reports in internal medicineCost-Effectiveness of 9-Valent HPV Vaccination for Patients Treated for High-Grade Cervical Intraepithelial Neoplasia in the UK.
JAMA network open[Recurrent respiratory papillomatosis].
Revue medicale suisseRecurrent respiratory papillomatosis: comparing in-office and operating room treatments.
Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-faccialeCharacterization of HPV6/11-reactive T-cell subsets in papillomas of patients with juvenile-onset recurrent respiratory papillomatosis and identification of HPV11 E7-specific candidate TCR clonotypes.
Journal of virologyQuantifying Bevacizumab Efficacy in Recurrent Respiratory Papillomatosis.
The LaryngoscopeMucosal Injection of the Silicon Phthalocyanine Pc 4 in a Rabbit Model-A Pilot Study.
The LaryngoscopeForecasting Disease Burden with a Dynamic Transmission Model of Human Papillomavirus and Recurrent Respiratory Papillomatosis in the United States.
Viruses[Step treatment of invasive recurrent respiratory papillomatosis in children: a case report].
Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgeryResults of CO2 laser surgery in laryngeal papillomatosis.
Oral oncologyEffectiveness of surgery combined with photodynamic therapy for recurrent respiratory papillomatosis.
American journal of otolaryngologyCell-free DNA analysis for recurrent respiratory papillomatosis: A case report.
Clinical case reports[Chinese guideline for the diagnosis and treatment of juvenile-onset recurrent respiratory papillomatosis (2024)].
Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgeryCough syncope and recurrent respiratory papillomatosis.
Lancet (London, England)A Consensus Statement on the Administration of Systemic Bevacizumab in Patients with Recurrent Respiratory Papillomatosis.
The LaryngoscopeVEGF as a Key Actor in Recurrent Respiratory Papillomatosis: A Narrative Review.
Current issues in molecular biologyAdjuvant Intralesional Bevacizumab in Pediatric and Adult Populations With Recurrent Respiratory Papillomatosis: A Systematic Review.
The Annals of otology, rhinology, and laryngologyA Case Report of Juvenile-Onset Recurrent Respiratory Papillomatosis.
CureusQuality of Life in Recurrent Respiratory Papillomatosis Patients after Vocal Fold Surgery: An In-Depth Exploration.
Folia phoniatrica et logopaedica : official organ of the International Association of Logopedics and Phoniatrics (IALP)Risk Factors for Procedural Complications of Pediatric Flexible Bronchoscopy: Experience From a Tertiary Care Centre in Northern India.
Indian pediatricsThe clinical characteristics of 1894 cases of upper respiratory papillomatosis: A single-center retrospective analysis.
American journal of otolaryngologyGlobal trends and hotspots on recurrent respiratory papillomatosis: A 20-year bibliometric analysis.
Laryngoscope investigative otolaryngologyIs there any interplay between human gut microbiota and upper airway susceptibility to recurrent respiratory papillomatosis exacerbations?
Otolaryngologia polska = The Polish otolaryngologyRemission of HPV-Related Diseases by Antivirals for Herpesvirus: Clinical Cases and a Literature Review.
VirusesGardasil® as adjunctive therapy for respiratory papillomatosis at Red Cross Children's Hospital, Cape Town.
Journal of the colleges of medicine of South Africa[Translated article] Treatment of juvenile recurrent respiratory papillomatosis in a pediatric lung transplant recipient.
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia HospitalariaJuvenile onset recurrent respiratory papillomatosis: What do we know in 2024 ?
Tumour virus researchHealthcare Spending and Systemic Bevacizumab for Recurrent Respiratory Papillomatosis.
Journal of voice : official journal of the Voice FoundationEffectiveness of combined approach to recurrent respiratory papillomatosis (RRP).
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck SurgeryThe role of HPV11 E7 in modulating STING-dependent interferon β response in recurrent respiratory papillomatosis.
Journal of virologyStructured Literature Review to Identify Human Papillomavirus's Natural History Parameters for Dynamic Population Models of Vaccine Impacts.
Infectious diseases and therapyHuman papillomavirus genotype distribution patterns in Zimbabwe; is the bivalent vaccine sufficient?
IntervirologyAngiogenesis Inhibitor Drug-induced Benign Migratory Glossitis in a Patient of Juvenile-onset Recurrent Respiratory Papillomatosis under Maintenance Therapy.
International journal of clinical pediatric dentistrySystemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Institution's Experience.
The LaryngoscopePulmonary Involvement in Recurrent Respiratory Papillomatosis: A Systematic Review.
Infectious disease reportsHuman papilloma virus (HPV) vaccination is associated with reduced number of surgical treatments, an observational study on recurrent respiratory papillomatosis in Northern Sweden.
Acta oto-laryngologicaDiode Laser for Juvenile Recurrent Respiratory Papillomatosis: A Case Series of 13 Patients.
Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of IndiaClinico-pathological Factors in Malignant Transformation of RRP.
Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of IndiaQuantification and Functional Studies of Neutrophilic Cells Identifies Distinct Papilloma Phenotypes.
The LaryngoscopeInvestigating immune and non-immune cellular profiles in recurrent respiratory papillomatosis by multi-omics.
Clinical and translational medicineCost-effectiveness of nonavalent HPV vaccination in the Netherlands.
Expert review of vaccinesAdjuvant Human Papillomavirus Vaccination in Recurrent Respiratory Papilloma Patients Older than 45.
The LaryngoscopeClinical significance of type IV vascularization of laryngeal lesions according to the Ni classification.
Frontiers in oncologyOff-label drugs in otolaryngological practice against the background of legal conditions of Polish legislation.
Otolaryngologia polska = The Polish otolaryngologyClinical evaluation of pediatric patients with recurrent respiratory papillomatosis.: A longitudinal study at a Saudi Arabian tertiary care center.
Saudi medical journalProfiling of VEGF Receptors and Immune Checkpoints in Recurrent Respiratory Papillomatosis.
The LaryngoscopeSystemic bevacizumab for treatment of recurrent respiratory papillomatosis.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck SurgeryFactors Associated with Iatrogenic Laryngeal Injury in Recurrent Respiratory Papillomatosis.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck SurgeryThe Larynx is Protected from Secondary and Vertical Papillomavirus Infection in Immunocompetent Mice.
The LaryngoscopeCimetidine for recurrent respiratory papillomatosis in pregnancy as an alternative adjuvant treatment.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck SurgeryA pilot study on salivary HPV DNA detection to monitor active disease from patients with recurrent respiratory papillomatosis.
American journal of otolaryngologyLaryngeal office-based procedures: A safe approach.
American journal of otolaryngologyA case report describing the use of systemic bevacizumab in the treatment of recurrent respiratory papillomatosis with pulmonary involvement.
Respirology case reportsTracheobronchopathia osteochondroplastica: a case report highlighting the importance of clinico-radiologic correlation.
BJR case reportsPlacental and Breast Metastasis of Squamous Cell Carcinoma in a Patient With Recurrent Respiratory Papillomatosis.
CureusThe tumor microenvironment state associates with response to HPV therapeutic vaccination in patients with respiratory papillomatosis.
Science translational medicineRecurrent respiratory papillomatosis disease course in immunosuppressed populations.
The Journal of laryngology and otologyIntralesional cidofovir vs. bevacizumab for recurrent respiratory papillomatosis: a systematic review and indirect meta-analysis.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck SurgeryAustralian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2022.
Communicable diseases intelligence (2018)Low-Dose Cisplatin-Based Radiation Therapy for Refractory Recurrent Respiratory Papillomatosis.
The LaryngoscopePublic health impact of 2-, 4-, and 9-valent HPV vaccination in females on cervical and noncervical diseases in men and women under different coverage scenarios in China: A simulation study.
Human vaccines & immunotherapeuticsUsefulness of Intraoperative Narrow-Band Imaging in the Site Diagnosis of Respiratory Papillomatosis.
The LaryngoscopeHPV-related diseases in male patients: an underestimated conundrum.
Journal of endocrinological investigationIndications, Efficacy, Safety, and Clinical Outcomes of 585 nm Pulsed Dye Laser in Non-Malignant Laryngeal Lesions: A Systematic Review.
Journal of personalized medicineRecurrent laryngeal papillomatosis: multimodal therapeutic strategies. Literature review and multicentre retrospective study.
Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-faccialeEnvironmental Sustainability: Waste Audit Comparison Operating Roomand In-Office Laryngeal Surgery.
The LaryngoscopeIntralesional Cidofovir: A Systematic Review of Administration Protocols and Long-term Recurrence Rates in Adult and Juvenile Recurrent Respiratory Papillomatosis.
Journal of voice : official journal of the Voice FoundationPublic health impact and cost-effectiveness of switching from bivalent to nonavalent vaccine for human papillomavirus in Norway: incorporating the full health impact of all HPV-related diseases.
Journal of medical economicsTransnasal Humidified Rapid Insufflation Ventilatory Exchange Augments Oxygenation in Children With Juvenile Onset Recurrent Respiratory Papillomatosis During Surgery: A Prospective Randomized Crossover Controlled Trial.
Anesthesia and analgesiaRecurrent respiratory papillomatosis (RRP) of tracheobronchial tree presenting as lung collapse with malignant transformation after a decade.
Respiratory medicine case reportsRecent Developments in Human Papillomavirus (HPV) Vaccinology.
VirusesEfficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement.
The LaryngoscopeRole Of CO2 Laser & Microdebrider In The Treatment Of Juvenile Onset Recurrent Respiratory Papillomatosi.
JPMA. The Journal of the Pakistan Medical AssociationRenal Implications of Long-Term Systemic Bevacizumab for Recurrent Respiratory Papillomatosis.
The Annals of otology, rhinology, and laryngology[Human papillomavirus prevalence and type distribution in Chinese juvenile-onset recurrent respiratory papillomatosis patients].
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhiRecurrent laryngeal papillomatosis with pulmonary involvement: case report.
Revista peruana de medicina experimental y salud publicaLaryngeal Suction tube: A Novel Technique for Tracheal Ventilation in an Obstructed Airway in a Child with Respiratory Papillomatosis.
Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of IndiaIntralesional Bevacizumab as Adjuvant Therapy for Juvenile Onset Recurrent Respiratory Papillomatosis: A Systematic Review.
Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of IndiaThe incidence of juvenile onset recurrent respiratory papillomatosis at Starship Children's Hospital before and after a national HPV vaccination programme: a retrospective review.
The New Zealand medical journalPreclinical Models of Laryngeal Papillomavirus Infection: A Scoping Review.
The LaryngoscopeComparison of three different image enhancement systems for detection of laryngeal lesions.
The Journal of laryngology and otologyInterim Results of a Phase 1/2 Open-Label Study of INO-3107 for HPV-6 and/or HPV-11-Associated Recurrent Respiratory Papillomatosis.
The LaryngoscopeSystemic bevacizumab for pediatric patients with aggressive recurrent respiratory papillomatosis: One single-center experience of eight patients.
Laryngoscope investigative otolaryngologyAssociation between human papillomavirus particle production and the severity of recurrent respiratory papillomatosis.
Scientific reportsRecurrent Respiratory Papillomatosis (RRP)-Meta-analyses on the use of the HPV vaccine as adjuvant therapy.
NPJ vaccinesUpdated estimate of the annual direct medical cost of screening and treatment for human papillomavirus associated disease in the United States.
VaccineSmoking and Carcinoma Trends in Recurrent Respiratory Papillomatosis Patients.
The Annals of otology, rhinology, and laryngologyOur experience in developing and operating the Airway Intervention Registry for Recurrent Respiratory Papillomatosis (AIR-RRP): national data collection.
NIHR open researchAggressive recurrent respiratory papillomatosis: A series of five consecutive patients successfully treated with adjuvant intravenous bevacizumab. A single Belgian academic center experience.
Head & neckLong-Term Follow-up of Parenteral Bevacizumab In Patients with Recurrent Respiratory Papillomatosis.
The LaryngoscopeMolecular Mechanisms of Carcinogenesis in Pediatric Airways Tumors.
International journal of molecular sciencesExperience with Systemic Bevacizumab in Advanced Juvenile Recurrent Respiratory Papillomatosis.
Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of IndiaTrace Elements Levels in Serum of Patients with Recurrent Respiratory Papillomatosis.
Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of IndiaAdult-onset Recurrent Respiratory Papillomatosis at a South African Referral Hospital.
Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of IndiaClinical and Public Health Considerations for HPV Vaccination in Midadulthood: A Narrative Review.
Open forum infectious diseasesRecurrent Respiratory Papillomatosis Presenting as Worsening Dyspnea in an HIV-infected Patient.
CureusSurgical outcome of different surgical modalities for adult recurrent respiratory papillomatosis.
Acta oto-laryngologicaHuman papillomavirus vaccination in Africa: An airway perspective.
International journal of pediatric otorhinolaryngologySystemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Scoping Review from 2009 to 2022.
Children (Basel, Switzerland)The Efficacy of Human Papillomavirus Vaccination as an Adjuvant Therapy in Recurrent Respiratory Papillomatosis.
The LaryngoscopeAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Papilomatose respiratória recorrente.
É de uma associação que acompanha esta doença? Fale com a gente →
Doença com base genética
Um médico geneticista pode ajudar no diagnóstico de Papilomatose respiratória recorrente e no aconselhamento genético da família.
Doenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Perguntas frequentes
O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu
A doença é causada pela infecção crônica do trato respiratório pelo vírus do papiloma humano. Essa infecção provoca o crescimento de papilomas na mucosa aerodigestiva, principalmente na região da laringe.
Referências
Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete
9 publicações do grafo RarasNet (PubMed) · 6 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Citar este verbete
Raras. (s.d.). Papilomatose respiratória recorrente. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/papilomatose-respiratoria-recorrente
Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Papilomatose respiratória recorrente
📋 Origem dos dados
Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.
- Doença rara (ontologia)
- fonte: Orphanet
- Identificador unificado
- fonte: MONDO
- Codificação WHO/SUS
- fonte: WHO ICD-10 / DATASUS
- CID-11 (futuro)
- fonte: WHO ICD-11
- NIH/GARD
- fonte: GARD (NIH)
- Indexação biomédica
- fonte: MeSH (NLM)
- Dado público estruturado
- fonte: Wikidata
- Medicamentos aprovados FDA
- fonte: FDA OpenFDA
- Ensaios clínicos
- fonte: ClinicalTrials.gov